A 53-year-old man has been tolerating elvitegravir-cobicistat-tenofovir DF-emtricitabine for 3 years, with consistent undetectable HIV RNA levels. He reports no side effects or missed doses. He asks if he should switch to a different regimen.
In a person with consistently suppressed HIV RNA levels, which one of the following reasons would be the lowest priority for switching to a different antiretroviral regimen?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
September 21st, 2023
September 21st, 2023
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5